According to Straits Research, the Non-Invasive Liquid Biopsy Market was valued at USD 1.58 billion in 2022 and is projected to witness significant growth, reaching USD 8.44 billion by 2031. The market is expected to expand at a robust CAGR of 20.38% during the forecast period (2023-2031), driven by advancements in diagnostic technologies, increase